Posts Tagged ‘Biotech’
Dr Andrea Pfeifer Retires From AC Immune
AC Immune SA, a Lausanne-based clinical-stage biopharmaceutical company pioneering precision therapeutics for neurodegenerative diseases, announces that Dr Andrea Pfeifer has decided to retire from her role as Chief Executive Officer (CEO) of AC Immune, after 23 years of tenure, at the upcoming Annual General Meeting (AGM) to spend more time with her family. Dr Pfeifer…
Read MoreSDSC and Canton of Vaud Support Bewe Lab and Perivision
Bewe Lab and Perivision are among the four companies selected by Canton de Vaud and the Swiss Data Science Center (SDSC) to join a new programme to help companies boost their projects with artificial intelligence and data science. The goal is to establish artificial intelligence as a key part of the Vaud economy. Bewe Lab:…
Read MoreImmitra Bio Receives a CHF 150,000 Gebert Rüf Stiftung InnoBooster Grant
Geneva-based startup Immitra Bio has been selected as one of the latest winners of the InnoBooster programme, supported by the Gebert Rüf Stiftung. This CHF 150,000 grant will be used to build a scalable in-vivo gene-editing platform to make genetic therapies accessible to all patients, regardless of where they live or their financial means. Founded…
Read MoreHAS Healthcare Advanced Synthesis Group Announces Strategic Investments in Biodelphis Therapeutics
HAS Healthcare Advanced Synthesis (Ticino) and Biodelphis Therapeutics (Vaud) announced the signing of a strategic agreement to support the development and GMP manufacturing of Antibody Protease Inhibitor Conjugates, an emerging class of targeted therapeutics designed to selectively inhibit disease‑driving proteases. This collaboration combines HAS Group long‑standing expertise in complex bioconjugation, process development, and clinical‑grade manufacturing…
Read MoreSwiss Biotech on the Rise: Strong Momentum in 2025
Switzerland’s biotech sector continues to demonstrate remarkable resilience and growth, even in a complex global environment. According to the latest Swiss Biotech Report 2026, the industry reached new heights in 2025—both in terms of revenue and investment—further strengthening the country’s position as a global life sciences powerhouse. Record performance in a challenging context The numbers…
Read MoreTwo Research Teams from HUG and UNIGE Awarded the 2026 Leenaards Scientific Prize
Two research groups from Hôpitaux Universitaires de Genève (HUG) and Université de Genève (UNIGE) have been awarded the 2026 Leenaards Foundation Scientific Prize, with total funding of nearly CHF 1.4 million. The award supports two biomedical research projects conducted in the Lake Geneva region, focusing respectively on hepatitis E and an innovative, non-invasive approach to…
Read Moreplanetary Raises CHF 16 Million to Advance Microprotein Production
planetary, a Geneva-based startup developing sustainable food ingredients through fermentation, has secured a CHF 16 million Series A funding round, complemented by CHF 6 million in credit. Over the last few month, the startup raises nearly CHF 34 million. The new financing will support the expansion of its fermentation infrastructure and the development of its…
Read MoreSeprify and BIOGRUND Join Forces
SilvaAlba™, a plant-based cellulose alternative to titanium dioxyde will developed by Seprify will be used by BIOGRUND, a specialist in coating solutions.
Read MoreONWARD Medical secures €40 million
ONWARD Medical has successfully raised more than €40 million in a capital increase, marking a significant milestone in its mission to restore movement and independence in people with spinal cord injuries. The financing round includes a €25 million investment from EQT Life Sciences, alongside strong support from leading institutional and sector-specialist investors. This new funding…
Read MoreThree Life Sciences Companies Finalist of the Strategis Award
The jury of the Prix Strategis selected five companies, to advance to the final round of the competition. Three of them are Swiss Health Valley projects. Irmos Technologies AG, which develops solutions to extend the lifespan of infrastructure. Neology SA, which offers a clean alternative to diesel. Virtuosis AI, specialized in intelligent vocal biomarkers. Isospec…
Read More